Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets
Jonatan Barrera‐Chimal, Frédéric Jaisser
Diabetes Obesity and Metabolism (2020) Vol. 22, Iss. S1, pp. 16-31
Open Access | Times Cited: 129

Showing 1-25 of 129 citing articles:

Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease
Chan‐Young Jung, Tae‐Hyun Yoo
Diabetes & Metabolism Journal (2022) Vol. 46, Iss. 2, pp. 181-197
Open Access | Times Cited: 117
Effects of Finerenone Combined with Empagliflozin in a Model of Hypertension-Induced End-Organ Damage
Peter Kolkhof, Elke Hartmann, Alexius Freyberger, et al.
American Journal of Nephrology (2021) Vol. 52, Iss. 8, pp. 642-652
Open Access | Times Cited: 108
Immune responses in diabetic nephropathy: Pathogenic mechanisms and therapeutic target
Jiahao Chen, Qinhui Liu, Jinhan He, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 97
Diabetic Nephropathy: Significance of Determining Oxidative Stress and Opportunities for Antioxidant Therapies
M. A. Darenskaya, С. И. Колесников, Н. В. Семенова, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12378-12378
Open Access | Times Cited: 45
Protective effect of orientin on diabetic nephropathy in rat models of high-fat diet and streptozotocin-induced diabetes
Raad Saad Luty, Adeeb Ahmed Al-Zubaidy, Arif Sami Malik, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access | Times Cited: 2
Roles and crosstalks of macrophages in diabetic nephropathy
Hai-Di Li, Yong‐Ke You, Baoyi Shao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 63
Nonsteroidal mineralocorticoid receptor antagonism for cardiovascular and renal disorders − New perspectives for combination therapy
Peter Kolkhof, Amer Joseph, Ulrich Kintscher
Pharmacological Research (2021) Vol. 172, pp. 105859-105859
Open Access | Times Cited: 56
Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice
Lee‐Ling Lim, Elaine Chow, Juliana C.N. Chan
Nature Reviews Endocrinology (2022) Vol. 19, Iss. 3, pp. 151-163
Closed Access | Times Cited: 50
The Role of Oxidative Stress-Mediated Inflammation in the Development of T2DM-Induced Diabetic Nephropathy: Possible Preventive Action of Tannins and Other Oligomeric Polyphenols
Gohar Sahakyan, Anne Véjux, Naira Sahakyan
Molecules (2022) Vol. 27, Iss. 24, pp. 9035-9035
Open Access | Times Cited: 41
The Bidirectional Link Between Diabetes and Kidney Disease: Mechanisms and Management
Mahendra Kumar, Shah Dev, Muhammad Khalid, et al.
Cureus (2023)
Open Access | Times Cited: 38
Cardiovascular Outcomes in Patients With Diabetes and Kidney Disease
Javier Morales, Yehuda Handelsman
Journal of the American College of Cardiology (2023) Vol. 82, Iss. 2, pp. 161-170
Open Access | Times Cited: 34
NAD metabolism modulates inflammation and mitochondria function in diabetic kidney disease
Komuraiah Myakala, Xiaoxin X. Wang, Nataliia V. Shults, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 8, pp. 104975-104975
Open Access | Times Cited: 27
Advances in Traditional Chinese Medicine research in diabetic kidney disease treatment
Shiyi Shen, Huiyun Zhong, Xiaoshi Zhou, et al.
Pharmaceutical Biology (2024) Vol. 62, Iss. 1, pp. 222-232
Open Access | Times Cited: 13
Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease
Julio M. Martínez‐Moreno, Miguel Fontecha‐Barriuso, Diego Martín‐Sánchez, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 4113-4113
Open Access | Times Cited: 54
Targeting inflammation for the treatment of Diabetic Kidney Disease: a five-compartment mechanistic model
Alexis Hofherr, Julie Williams, Li‐Ming Gan, et al.
BMC Nephrology (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 32
Nonsteroidal Mineralocorticoid Receptor Antagonism by Finerenone—Translational Aspects and Clinical Perspectives across Multiple Organ Systems
Peter Kolkhof, Robert Lawatscheck, Gerasimos Filippatos, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9243-9243
Open Access | Times Cited: 27
Change in albuminuria as a surrogate endpoint for cardiovascular and renal outcomes in patients with diabetes
Biff F. Palmer
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 6, pp. 1434-1443
Open Access | Times Cited: 14
Impact of SGLT2 inhibitors on patient outcomes: a network meta-analysis
Jui‐Yi Chen, Heng‐Chih Pan, Chih‐Chung Shiao, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 14
ADP-Ribosylation Factor-Interacting Protein 2 Acts as a Novel Regulator of Mitophagy and Autophagy in Podocytes in Diabetic Nephropathy
Haihua Guo, Manuel Rogg, Julia Keller, et al.
Antioxidants (2024) Vol. 13, Iss. 1, pp. 81-81
Open Access | Times Cited: 5
Parallelism and non-parallelism in diabetic nephropathy and diabetic retinopathy
Shanshan Tang, Xuedong An, Wenjie Sun, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 5
Unraveling DDIT4 in the VDR-mTOR pathway: a novel target for drug discovery in diabetic kidney disease
Haitao Lu, Yuanyuan Jiao, Tianyu Yu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
The Potential of DC Immunotherapy in Improving Proteinuria in Type 2 Diabetes Mellitus
Jonny Jonny, Enda Cindylosa Sitepu, I Nyoman Ehrich Lister, et al.
(2024)
Open Access | Times Cited: 5
Epigenetics in kidney diseases
Hao Ding, Lu Zhang, Qian Yang, et al.
Advances in clinical chemistry (2020), pp. 233-297
Open Access | Times Cited: 37
Mini-Review: GSDME-Mediated Pyroptosis in Diabetic Nephropathy
Wen Li, Jing Sun, Xiaoxi Zhou, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 32
Roles of SIRT6 in kidney disease: a novel therapeutic target
Xueyan Yang, Jun Feng, Wei Liang, et al.
Cellular and Molecular Life Sciences (2021) Vol. 79, Iss. 1
Closed Access | Times Cited: 31
Page 1 - Next Page

Scroll to top